Back to Authors

Johnson, Geoffrey B

0000-0002-4866-1401

Mayo Clinic

Mayo Clinic

Citations 16

Can Hybrid PET/MRI Advance Precision Imaging in Cardiomyopathy?
Kusmirek, Joanna E. , Johnson, Geoffrey B , Johnson, Geoffrey B.

Radiology | June 16, 2026 | Volume: 319 | Issue: 3 | Pages: No page available

10.1148/radiol.261072 Get It

PET/MRI: Where might it replace PET/CT?
Ehman, Eric C. , Johnson, Geoffrey B. , Leynes, Andrew P. , Johnson, Geoffrey B. , Villanueva-Meyer, Javier E. , Cha, Soonmee , Larson, Peder E. Z. , Hope, Thomas A. , Johnson, Geoffrey B , Johnson, Geoffrey B

Journal of Magnetic Resonance Imaging | March 31, 2017 | Volume: 46 | Issue: 5 | Pages: 1247-1262

10.1002/jmri.25711 Get It

Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that combines the anatomic and quantitative strengths of MR imaging with physiologic information obtained from PET. PET and computed tomography (PET/CT) performed in a single scanning session is an established technology already in widespread and accepted use worldwide. Given the higher cost and complexity of operating and interpreting the studies obtained on a PET/MRI system, there has been question as to which patients would benefit most from imaging with PET/MRI versus PET/CT. In this article, we compare PET/MRI with PET/CT, detail the applications for which PET/MRI has shown promise and discuss impediments to future adoption. It is our hope that future work will prove the benefit of PET/MRI to specific groups of patients, initially those in which PET/CT and MRI are already performed, leveraging simultaneity and allowing for greater degrees of multiparametric evaluation.Level of Evidence: 5Technical Efficacy: Stage 5J. Magn. Reson. Imaging 2017;46:1247–1262.
Detection of ALECT2 amyloidosis by positron emission tomography–computed tomography imaging with florbetapir
Ramı́rez-Alvarado, Marina , Nasr, Samih H. , Kemp, Bradley J. , Johnson, Geoffrey B. , Johnson, Geoffrey B. , Ramirez-Alvarado, Marina, Leung, Nelson , Johnson, Geoffrey B , Ramirez-Alvarado, Marina , Johnson, Geoffrey B

British Journal of Haematology | January 20, 2017 | Volume: 177 | Issue: 1 | Pages: 12-12

10.1111/bjh.14519 Get It

Pseudomyxoma Pleuri. A Rare Manifestation of an Uncommon Disease
Gutiérrez, María del Valle Somiedo, Lee, Christine U. , Johnson, Geoffrey B. , Maldonado, Fabien , Johnson, Geoffrey B. , Villasboas, José C. , Shen, Robert K. , Johnson, Geoffrey B , Johnson, Geoffrey B

American Journal of Respiratory and Critical Care Medicine | June 2, 2015 | Volume: 191 | Issue: 11 | Pages: 1334-1335

10.1164/rccm.201412-2246im Get It

Targeting B Lymphocytes in Progressive Fibrosing Mediastinitis
Westerly, Blair, Johnson, Geoffrey B. , Maldonado, Fabien , Utz, James P., Peikert, Tobias, Johnson, Geoffrey B. , Westerly, Blair D, Specks, Ulrich , Johnson, Geoffrey B , Johnson, Geoffrey B

American Journal of Respiratory and Critical Care Medicine | October 31, 2014 | Volume: 190 | Issue: 9 | Pages: 1069-1071

10.1164/rccm.201407-1258le Get It

Pulmonary masses in a patient with dyspnea: Apply Occam's razor or Hickam's dictum?
Leung, Nelson , Grogan, Martha , Johnson, Geoffrey B. , Klecka, Mary E., Dispenzeiri, Angela, Johnson, Geoffrey B. , Leung, Nelson , Johnson, Geoffrey B , Johnson, Geoffrey B

American Journal of Hematology | October 9, 2014 | Volume: 90 | Issue: 5 | Pages: 462-465

10.1002/ajh.23870 Get It

Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 4
Johnson, Geoffrey B. , Brunn, Gregory J., Platt, Jeffrey L. , Johnson, Geoffrey B. , Johnson, Geoffrey B , Johnson, Geoffrey B

The Journal of Immunology | April 20, 2014 | Volume: 172 | Issue: 1 | Pages: 20-24

10.4049/jimmunol.172.1.20 Get It

Abstract Systemic inflammatory response syndrome (SIRS) is typically associated with trauma, surgery, or acute pancreatitis. SIRS resembles sepsis, triggered by exogenous macromolecules such as LPS acting on Toll-like receptors. What triggers SIRS in the absence of infection, however, is unknown. In this study, we report that a SIRS-like response can be induced in mice by administration of soluble heparan sulfate, a glycosaminoglycan associated with nucleated cells and extracellular matrices, and by elastase, which cleaves and releases heparan sulfate proteoglycans. The ability of heparan sulfate and elastase to induce SIRS depends on functional Toll-like receptor 4, because mutant mice lacking that receptor or its function do not respond. These results provide a molecular explanation for the initiation of SIRS.